Arbër Hyseni is an associate on the Corporate/M&A team at Walder Wyss. His preferred areas of practice include domestic and cross-border mergers and acquisitions, corporate law, commercial law, capital markets law, as well as general contract law.

Arbër Hyseni studied law at the University of Zurich (BLaw 2020, MLaw 2022) and the University of Lausanne (MLaw 2022, Joint Degree). Before starting his career as an attorney, Arbër Hyseni worked as a trainee lawyer at Walder Wyss and as a law clerk at the District Attorney's Office in Zürich. He was admitted to the bar in 2026.

Arbër Hyseni practices in both German and English. He also speaks French and Albanian and has basic knowledge of Spanish.

Significant Accomplishments

Corient acquires Stonehage Fleming and Stanhope Capital

Voliro announces Series A Extension

Ypsomed verkauft ihr Diabetes-Care-Geschäft an TecMed AG

Walder Wyss advised Nasdaq listed Altamira Therapeutics in its sale of majority stake in Altamira Medica

Walder Wyss advised Ionisos group

Bota Systems AG announces the completion of USD 2.5m Seed Round

Best Price Rule in Public Takeovers - MINOR Changes, MAJOR Effect
Different Requirements for Different Opting Out Clauses under Swiss Public Takeover Rules
Liquidation of unprofitable business by the target company as a permissible condition to a public offer
Die Abwicklung von unrentablen Geschäftsbereichen durch die Zielgesellschaft als zulässige Bedingung eines öffentlichen Angebots